FDA Warning Letter — Rubix

Case 692225 — FEI 3014231143

The FDA took a Warning Letter action against Rubix on Sep 10, 2024 (Cincinnati, OH). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Rubix
Date
Sep 10, 2024
Fiscal Year
2024
Product Type
Tobacco
Center
CTP
Location
Cincinnati, OH (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.